These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 35700041)

  • 21. Automated brainstem volumetry can aid in the diagnostics of parkinsonian disorders.
    Sjöström H; Granberg T; Hashim F; Westman E; Svenningsson P
    Parkinsonism Relat Disord; 2020 Oct; 79():18-25. PubMed ID: 32858488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contribution of MRI for the Early Diagnosis of Parkinsonism in Patients with Diagnostic Uncertainty.
    Chougar L; Faucher A; Faouzi J; Lejeune FX; Gama Lobo G; Jovanovic C; Cormier F; Dupont G; Vidailhet M; Corvol JC; Colliot O; Lehéricy S; Grabli D; Degos B
    Mov Disord; 2024 May; 39(5):825-835. PubMed ID: 38486423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MRI measurements predict PSP in unclassifiable parkinsonisms: a cohort study.
    Morelli M; Arabia G; Novellino F; Salsone M; Giofrè L; Condino F; Messina D; Quattrone A
    Neurology; 2011 Sep; 77(11):1042-7. PubMed ID: 21832222
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Contribution of the Mesencephalon Indices to Differential Diagnosis of Parkinsonian Disorders.
    Oktay C; Özkaynak SS; Eseroğlu E; Karaali K
    Can Assoc Radiol J; 2020 Feb; 71(1):100-109. PubMed ID: 32062996
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphometry MRI in the differential diagnosis of parkinsonian syndromes.
    Gama RL; Távora DF; Bomfim RC; Silva CE; Bruin VM; Bruin PF
    Arq Neuropsiquiatr; 2010 Jun; 68(3):333-8. PubMed ID: 20602031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic Resonance Parkinsonism Index: diagnostic accuracy of a fully automated algorithm in comparison with the manual measurement in a large Italian multicentre study in patients with progressive supranuclear palsy.
    Nigro S; Arabia G; Antonini A; Weis L; Marcante A; Tessitore A; Cirillo M; Tedeschi G; Zanigni S; Calandra-Buonaura G; Tonon C; Pezzoli G; Cilia R; Zappia M; Nicoletti A; Cicero CE; Tinazzi M; Tocco P; Cardobi N; Quattrone A
    Eur Radiol; 2017 Jun; 27(6):2665-2675. PubMed ID: 27761709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Iron deposition in Parkinsonisms: A Quantitative Susceptibility Mapping study in the deep grey matter.
    Fedeli MP; Contarino VE; Siggillino S; Samoylova N; Calloni S; Melazzini L; Conte G; Sacilotto G; Pezzoli G; Triulzi FM; Scola E
    Eur J Radiol; 2020 Dec; 133():109394. PubMed ID: 33190103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of substantia nigra hyperintensity on 7 Tesla MRI of Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy.
    Kim JM; Jeong HJ; Bae YJ; Park SY; Kim E; Kang SY; Oh ES; Kim KJ; Jeon B; Kim SE; Cho ZH; Kim YB
    Parkinsonism Relat Disord; 2016 May; 26():47-54. PubMed ID: 26951846
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders.
    Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C
    J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development and Validation of Automated Magnetic Resonance Parkinsonism Index 2.0 to Distinguish Progressive Supranuclear Palsy-Parkinsonism From Parkinson's Disease.
    Quattrone A; Bianco MG; Antonini A; Vaillancourt DE; Seppi K; Ceravolo R; Strafella AP; Tedeschi G; Tessitore A; Cilia R; Morelli M; Nigro S; Vescio B; Arcuri PP; De Micco R; Cirillo M; Weis L; Fiorenzato E; Biundo R; Burciu RG; Krismer F; McFarland NR; Mueller C; Gizewski ER; Cosottini M; Del Prete E; Mazzucchi S; Quattrone A
    Mov Disord; 2022 Jun; 37(6):1272-1281. PubMed ID: 35403258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations.
    Paviour DC; Price SL; Jahanshahi M; Lees AJ; Fox NC
    Mov Disord; 2006 Jul; 21(7):989-96. PubMed ID: 16602104
    [TBL] [Abstract][Full Text] [Related]  

  • 32. White matter and cortical changes in atypical parkinsonisms: A multimodal quantitative MR study.
    Zanigni S; Evangelisti S; Testa C; Manners DN; Calandra-Buonaura G; Guarino M; Gabellini A; Gramegna LL; Giannini G; Sambati L; Cortelli P; Lodi R; Tonon C
    Parkinsonism Relat Disord; 2017 Jun; 39():44-51. PubMed ID: 28291592
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnostic accuracy of MR planimetry in clinically unclassifiable parkinsonism.
    Heim B; Mangesius S; Krismer F; Wenning GK; Hussl A; Scherfler C; Gizewski ER; Schocke M; Esterhammer R; Quattrone A; Poewe W; Seppi K
    Parkinsonism Relat Disord; 2021 Jan; 82():87-91. PubMed ID: 33271461
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dorsolateral nigral hyperintensity on 3.0T susceptibility-weighted imaging in neurodegenerative Parkinsonism.
    Reiter E; Mueller C; Pinter B; Krismer F; Scherfler C; Esterhammer R; Kremser C; Schocke M; Wenning GK; Poewe W; Seppi K
    Mov Disord; 2015 Jul; 30(8):1068-76. PubMed ID: 25773707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Nigral Hyperintensity on 3 Tesla MRI of Parkinsonism: Comparison With (123) I-FP-CIT SPECT.
    Bae YJ; Kim JM; Kim E; Lee KM; Kang SY; Park HS; Kim KJ; Kim YE; Oh ES; Yun JY; Kim JS; Jeong HJ; Jeon B; Kim SE
    Mov Disord; 2016 May; 31(5):684-92. PubMed ID: 26990970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apparent diffusion coefficient of the superior cerebellar peduncle differentiates progressive supranuclear palsy from Parkinson's disease.
    Nicoletti G; Tonon C; Lodi R; Condino F; Manners D; Malucelli E; Morelli M; Novellino F; Paglionico S; Lanza P; Messina D; Barone P; Morgante L; Zappia M; Barbiroli B; Quattrone A
    Mov Disord; 2008 Dec; 23(16):2370-6. PubMed ID: 18816803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Novel decision algorithm to discriminate parkinsonism with combined blood and imaging biomarkers.
    Mangesius S; Mariotto S; Ferrari S; Pereverzyev S; Lerchner H; Haider L; Gizewski ER; Wenning G; Seppi K; Reindl M; Poewe W
    Parkinsonism Relat Disord; 2020 Aug; 77():57-63. PubMed ID: 32622301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differentiating PSP from MSA using MR planimetric measurements: a systematic review and meta-analysis.
    Heim B; Krismer F; Seppi K
    J Neural Transm (Vienna); 2021 Oct; 128(10):1497-1505. PubMed ID: 34105000
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiomics on routine T1-weighted MRI can delineate Parkinson's disease from multiple system atrophy and progressive supranuclear palsy.
    Tupe-Waghmare P; Rajan A; Prasad S; Saini J; Pal PK; Ingalhalikar M
    Eur Radiol; 2021 Nov; 31(11):8218-8227. PubMed ID: 33945022
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A new MR imaging index for differentiation of progressive supranuclear palsy-parkinsonism from Parkinson's disease.
    Quattrone A; Morelli M; Nigro S; Quattrone A; Vescio B; Arabia G; Nicoletti G; Nisticò R; Salsone M; Novellino F; Barbagallo G; Le Piane E; Pugliese P; Bosco D; Vaccaro MG; Chiriaco C; Sabatini U; Vescio V; Stanà C; Rocca F; Gullà D; Caracciolo M
    Parkinsonism Relat Disord; 2018 Sep; 54():3-8. PubMed ID: 30068492
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.